KLHL10 inhibitors are small molecules designed to target and interfere with the activity of the KLHL10 protein. KLHL10, or Kelch-like family member 10, is part of the larger Kelch-like protein family, characterized by their highly conserved BTB (Bric-a-brac, Tramtrack, Broad Complex) domain, which mediates protein-protein interactions. Additionally, these proteins contain Kelch repeats that form a β-propeller structure, facilitating substrate recognition. KLHL10 is known to function as an adaptor protein within E3 ubiquitin ligase complexes, where it aids in the ubiquitination and subsequent degradation of specific substrates, a key regulatory process for maintaining protein homeostasis. Inhibitors of KLHL10 typically work by binding to this protein, obstructing its interactions within the ubiquitin-proteasome system.
These inhibitors are developed using diverse chemistries, with molecular scaffolds that can interfere with the protein's substrate recognition or its dimerization ability. Structurally, these compounds are optimized to interact with the BTB domain or the Kelch repeats, disrupting the formation of functional complexes necessary for ubiquitination. Many of these inhibitors exhibit specificity by targeting the precise interfaces responsible for KLHL10's protein-protein interactions, avoiding broader effects on other Kelch-like proteins. The design and modification of KLHL10 inhibitors rely heavily on structural biology and computational modeling to refine interactions with the protein's active sites. This high level of specificity allows for a detailed understanding of the role KLHL10 plays in various biological processes. KLHL10 inhibitors are valuable molecular tools in studying the regulation of ubiquitination pathways and protein degradation.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
MG-132 [Z-Leu- Leu-Leu-CHO] | 133407-82-6 | sc-201270 sc-201270A sc-201270B | 5 mg 25 mg 100 mg | $60.00 $265.00 $1000.00 | 163 | |
Proteasome inhibitor that stabilizes proteins targeted for degradation; this prevents the degradation of regulatory proteins that control the stability and expression of KLHL10. | ||||||
Epoxomicin | 134381-21-8 | sc-201298C sc-201298 sc-201298A sc-201298B | 50 µg 100 µg 250 µg 500 µg | $137.00 $219.00 $449.00 $506.00 | 19 | |
Selective proteasome inhibitor that can increase the levels of regulatory proteins involved in maintaining KLHL10 expression and stability. | ||||||
Ivermectin | 70288-86-7 | sc-203609 sc-203609A | 100 mg 1 g | $57.00 $77.00 | 2 | |
Binds to and modulates ion channels; alters cellular ion balance, which can influence signaling pathways regulating KLHL10 expression. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Glycogen synthase kinase-3 (GSK-3) inhibitor; modifies signaling pathways that can stabilize transcription factors regulating KLHL10 gene expression. | ||||||
SB-216763 | 280744-09-4 | sc-200646 sc-200646A | 1 mg 5 mg | $71.00 $202.00 | 18 | |
GSK-3 inhibitor that can lead to the stabilization of transcription factors implicating in the control of KLHL10 expression. | ||||||
Bortezomib | 179324-69-7 | sc-217785 sc-217785A | 2.5 mg 25 mg | $135.00 $1085.00 | 115 | |
Proteasome inhibitor that can disrupt the degradation pathways of proteins that regulate KLHL10 expression and stability. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
MEK inhibitor that alters ERK/MAPK signaling, impacting the post-translational modifications of proteins involved in KLHL10 regulation. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
Inhibits JNK, modifying the JNK signaling pathway which can affect transcription factors and other regulatory proteins that control KLHL10 expression. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
Phosphoinositide 3-kinases (PI3K) inhibitor; affects AKT signaling and can alter the activity of transcription factors that regulate KLHL10. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
mTOR inhibitor that can change the activity of downstream targets involved in the regulation of protein synthesis, including proteins that control KLHL10 expression. | ||||||